2021 annual financial data
Altimmune 2021 Operating margin
Direct answer
Operating margin was -2,197.6%.
Operating income was -96,914,000 USD and net income was -97,090,000 USD.
Operating cash flow was -78,238,000 USD.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,410,000 USD
- Operating income
- -96,914,000 USD
- Net income
- -97,090,000 USD
- Operating cash flow
- -78,238,000 USD